Sign up to save your podcasts
Or
Share Rare Melanomas Prove 'Hard to Get' Using Immunotherapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Rare Melanomas Prove 'Hard to Get' Using Immunotherapy
Dr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma.
View all episodes
By MedscapeDr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma.